精密医療における肺動脈高血圧の診断と患者のプロフィールに関する進歩
Benedetta Ricchi1, Vineeta Jagana1, Elizabeth Singh1
1Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA.
Therapeutic advances in respiratory disease
|August 29, 2025
まとめ
肺動脈高血圧 (PAH) は重症である. 早期診断と革新的な治療法は この進行性血管疾患の患者の治療結果を改善するために不可欠です
科学分野:
- 心臓病科
- 肺科
- 血管生物学
背景:
- 肺動脈高血圧 (PAH) は,進行的な血管改造と右心房 (RV) 機能不全を引き起こす致命的な疾患です.
- 遅い診断は 治療の有効性を制限し 検出方法の改善が不可欠であることを強調しています
- PAHの病理生理学には,増殖と代謝再プログラムを含む分子経路と癌のような細胞行動が含まれています.
研究 の 目的:
- 肺動脈高血圧 (PAH) の臨床および診断研究に関する新しい洞察を提供すること.
- PAHの分類,イメージング,遺伝子検査の進歩について議論する.
- PAHの検出と管理における人工知能の役割を調査する.
主な方法:
- 肺動脈高血圧 (PAH) の現在の臨床および診断研究のレビュー.
- イメージと遺伝子検査を含む既定および新興の診断方法の議論
- PAH診断のワークフローにおける人工知能の応用に関する調査
主要な成果:
- 現在の分類システムは適切ですが,継続的な評価が必要です.
- 革新的なイメージングと遺伝子検査はPAHを早期に特定する可能性を秘めています.
- 人工知能は 病気の検出と管理の改善に 期待を寄せています
結論:
- 肺動脈高血圧 (PAH) の早期診断は,効果的な治療に不可欠です.
- パーソナライズされた治療戦略と継続的なイノベーションは 患者の治療結果を改善するために不可欠です
- AIを含む診断の進歩は,よりよいPAH治療の鍵です.
関連する概念動画
01:30Pulmonary Hypertension: Classification and Pathogenesis
284
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
284
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
253
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
253
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
317
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
317
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
251
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
251
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K